Advanced search

1747 Results

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Arthur J. Gallagher & Co. Announces First Quarter 2024 Financial Results	04:16pm	PR
Willis Towers Watson Public : Q1 2024 Supplemental Slides	06:42am	PU
Acadia Pharmaceuticals Announces Trofinetide New Drug Submission for Treatment of Rett Syndrome Has Been Accepted for Filing and Priority Review by Health Canada	Apr. 22	BU
Letshego Africa : Notice of Unclaimed Dividends	Apr. 22	PU
Acadia Pharmaceuticals Presents New DAYBUE™ (trofinetide) Clinical Data at the 2024 American Academy of Neurology (AAN) Annual Meeting	Apr. 17	BU
Volkswagen : Report of the Supervisory Board	Apr. 17	PU
Sip with Me Cups now Available at Landry’s Rainforest Café	Apr. 10	AQ
Nouveau Monde Graphite : NOTICE AND MANAGEMENT INFORMATION CIRCULAR - Form 6-K	Apr. 09	PU
Blue Owl Capital Inc. entered into an agreement to acquire Prima Capital Advisors LLC from Stone Point Capital LLC for approximately $220 million.	Apr. 08	CI
Aris Mining : NOTICE OF 2024 ANNUAL GENERAL MEETING OF SHAREHOLDERS AND MANAGEMENT INFORMATION CIRCULAR - Form 6-K	Apr. 08	PU
The Fed and investors agree on the timing of rate cuts	Apr. 02
ANALYST RECOMMENDATIONS : Estee Lauder, Humana, Eli Lilly, National Grid, Brown-Forman...	Apr. 02
Yield10 Bioscience : 2024 Special Meeting of Stockholders	Apr. 01	PU
Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights	Apr. 01	AQ
Zions Bancorporation N A : 2023 Annual Report Officers & Directors	Mar. 28	PU
SPX Technologies : Investor Day Presentation	Mar. 26	PU
Tonix Pharmaceuticals Receives Rare Pediatric Disease Designation from the FDA for TNX-2900 for the Treatment of Prader-Willi Syndrome	Mar. 25	AQ
Fortis : Message from the Chair of the Board and the President and Chief Executive Officer - Form 6-K	Mar. 25	PU
Rogers Communications : Who We Are - Form 6-K	Mar. 22	PU
Tonix Pharmaceuticals Announces Poster Presentation Describing Discovery of Novel Next-Generation Oxytocin Analogues at the American Chemistry Society (ACS) Spring 2024 Meeting	Mar. 21	AQ
Bancorp 34, Inc. completed the acquisition of CBOA Financial, Inc..	Mar. 18	CI
Meyer Burger Technology : Online-Geschäftsbericht 2023	Mar. 14	PU
Meyer Burger Technology : Fiscal year report 2023	Mar. 14	PU
North American Morning Briefing : Stock Futures -2-	Mar. 13	DJ
Copart, Inc. Announces Board Changes	Mar. 12	CI
Medartis : Corporate Governance Bericht 2023 (ENG)	Mar. 12	PU
Soleno Therapeutics : March 2024 Corporate Presentation	Mar. 04	PU
Bancorp 34, Inc. completed the acquisition of CBOA Financial, Inc..	Mar. 03	CI
North American Morning Briefing : Stock Futures Edge Down After Record Nasdaq Close	Mar. 01	DJ
Transcript : XPS Pensions Group plc - Special Call	Feb. 29
Acadia Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Operating Overview	Feb. 27	BU
ANALYST RECOMMENDATIONS : Airbnb, Conagra Brands, Berkshire Hathaway, Meta Platforms, Unilever....	Feb. 21
Positive Feasibility Results Establish Cordero as One of the World’s Leading Development-Stage Silver Projects	Feb. 20	GL
Less is more? Consumers have fewer choices as brands prune their offerings to focus on best sellers	Feb. 12	AQ
Tonix Pharmaceuticals Announces FDA IND Clearance for DoD Funded Trial of TNX-102 SL for the Reduction of Acute Stress Reaction and Prevention of PTSD	Feb. 12	AQ
Canopy Growth Reports Third Quarter Fiscal Year 2024 Financial Results; Achieves Third Quarter of Sequential Revenue Growth across Canada Cannabis Businesses and a Record Quarter for Medical Sales	Feb. 09	AQ
Canopy Growth Corporation Announces Board Changes	Feb. 09	CI
That's good enough for investors	Feb. 06
Tonix Pharmaceuticals Announces Research Indicating Pre-Existing Fibromyalgia-Type Symptoms May Increase the Risk of Developing Long COVID	Jan. 31	AQ
Acadia Announces Additions to Executive Team	Jan. 30	BU
Transcript : Arthur J. Gallagher & Co., Q4 2023 Earnings Call, Jan 25, 2024	Jan. 25
Arthur J. Gallagher & Co. Announces Fourth Quarter and Full Year 2023 Financial Results	Jan. 25	PR
Starbucks Elects Daniel Servitje, Neal Mohan and Mike Sievert to its Board of Directors	Jan. 09	BU
Tonix Pharmaceuticals Announces Highly Statistically Significant and Clinically Meaningful Topline Results in Second Positive Phase 3 Clinical Trial of TNX-102 SL for the Management of Fibromyalgia	Dec. 20	AQ
Transcript : Arthur J. Gallagher & Co. - Special Call	Dec. 13
WTW appoints Chris Condello to Head Newly Created Asia Risk Division within CRB, North America	Dec. 04	AQ
Tonix Pharmaceuticals Announces IND Clearance by the FDA for Phase 2 Trial of TNX-2900 for the Treatment of Prader-Willi Syndrome, the Most Common Genetic Cause of Life-Threatening Childhood Obesity	Dec. 04	AQ
Acadia Pharmaceuticals Initiates Pivotal Phase 3 Study of Carbetocin (ACP-101) for the Treatment of Hyperphagia in Prader-Willi Syndrome	Nov. 30	BU
Notice of AGM: December 2023	Nov. 28	PU
Acadia Pharmaceuticals Initiates Phase 2 Clinical Trial of ACP-204 for the Treatment of Alzheimer’s Disease Psychosis	Nov. 27	BU

No results for this search

Like the pros, access all the transcripts and spot the best opportunities before anyone else.

Unlock them now!

fermer